Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICARIOS: Celivarone for Prevention of ICD Interventions
NCT00232297Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of celivarone in ventricular arrhythmia (VA), ventricular tachycardia (VT), ventricular fibrillation (VF), sponsored by Sanofi. Started Jun 2005; status: completed.
02
Drugs
celivarone
03
Conditions
ventricular arrhythmia (VA)ventricular tachycardia (VT)ventricular fibrillation (VF)
Beyond the preview
Go deeper on NCT00232297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232297.